Your browser doesn't support javascript.
loading
Left atrial appendage closure outcomes in relation to atrial fibrillation patterns: a comprehensive analysis.
Zhao, Mingzhong; Yu, Jiangtao; Hou, Cody R; Post, Felix; Zhang, Lei; Xu, Yuhui; Herold, Nora; Walsleben, Jens.
Afiliación
  • Zhao M; Cardiovascular Center, Chengdu Shuangnan Hospital, Chengdu, China.
  • Yu J; Heart Center, Zhengzhou Ninth People's Hospital, Zhengzhou, China.
  • Hou CR; Department of Cardiology, Helmut-G.-Walther-Klinikum, Lichtenfels, Germany.
  • Post F; Department of Cardiology, Helmut-G.-Walther-Klinikum, Lichtenfels, Germany.
  • Zhang L; Clinic for General Internal Medicine and Cardiology, Catholic Medical Center Koblenz-Montabaur, Koblenz, Germany.
  • Xu Y; Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, United States.
  • Herold N; Clinic for General Internal Medicine and Cardiology, Catholic Medical Center Koblenz-Montabaur, Koblenz, Germany.
  • Walsleben J; Cardiovascular Center, Chengdu Shuangnan Hospital, Chengdu, China.
Front Cardiovasc Med ; 11: 1389811, 2024.
Article en En | MEDLINE | ID: mdl-38841258
ABSTRACT

Objective:

The effect of atrial fibrillation (AF) patterns on outcomes remains controversial. This study aims to evaluate the influence of AF type on the risk of cardiocerebrovascular events after left atrial appendage closure (LAAC) at long-term follow-up.

Methods:

AF was categorized as paroxysmal AF (PAF) and non-PAF (NPAF). The baseline characteristics, procedural data, peri-procedural complications, and long-term outcomes between patients with PAF and NPAF after LAAC were compared.

Results:

We analyzed 410 AF patients (mean age 74.8 ± 8.2 years; 271 male; 144 with PAF, 266 NPAF). The NPAF group tended to be older (≥75 years), male, and have chronic kidney disease (CKD) compared with the PAF group. The procedural data and peri-procedural complications were comparable. During 2.2 ± 1.5 years of follow-up, the incidences of thromboembolism, major bleeding, and device-related thrombus (DRT) did not differ between the two groups. The observed risk of thromboembolism and major bleeding was significantly lower than the estimated risk based on the CHA2DS2-VASc and HAS-BLED scores, respectively, in patients who underwent LAAC, regardless of the AF type. NPAF patients were associated with a higher risk of all-cause mortality, non-cardiovascular mortality, and combined efficacy endpoints. This association disappeared after propensity score matching (PSM) analysis.

Conclusions:

The risk of thromboembolism and major bleeding was lower in patients who underwent LAAC, regardless of the AF type. Although NPAF often coexists with multiple risk factors, it was not associated with worse long-term outcomes after LAAC when compared with PAF.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Cardiovasc Med Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Cardiovasc Med Año: 2024 Tipo del documento: Article País de afiliación: China
...